CSS
GEVA

Cubist Systematic Strategies’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Cubist Systematic Strategies’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,447
Closed -$239K – 2268
2015
Q1 		$239K Buy
+2,447
New +$259K 0.01% 1409

Cubist Systematic Strategies's GEVA Position: Q2 2015 in Review

Cubist Systematic Strategies sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 2,447 shares — an estimated $239K sold.

Cubist Systematic Strategies first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $239K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Cubist Systematic Strategies reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Cubist Systematic Strategies sold 2,447 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $239K.
  • Cubist Systematic Strategies first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Cubist Systematic Strategies's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $239K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Cubist Systematic Strategies's 13F filing for Q2 2015, filed 14 Aug 2015.